Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Tools to improve frailty assessment in patients with multiple myeloma

Elizabeth O’Donnell, MD, Dana-Farber Cancer Institute, Boston, MA, discusses tools used to assess frailty in patients with multiple myeloma, such as the International Myeloma Working Group (IMWG) frailty score and the Charlson Comorbidity Index (CCI), and further comments on the importance of incorporating these tools into clinical trial design. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.